[
    [
        {
            "time": "",
            "original_text": "万泰生物(603392.SH)两名董监高计划减持合计不超40万股",
            "features": {
                "keywords": [
                    "万泰生物",
                    "董监高",
                    "减持",
                    "40万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "万泰生物(603392.SH)：总工程师李益民及副总经理李莎燕拟分别减持不超20万股 拟减持股份",
            "features": {
                "keywords": [
                    "万泰生物",
                    "李益民",
                    "李莎燕",
                    "减持",
                    "20万股"
                ],
                "sentiment_score": -0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "万泰生物：李益民、李莎燕拟合计减持不超过40万股 拟减持股份",
            "features": {
                "keywords": [
                    "万泰生物",
                    "李益民",
                    "李莎燕",
                    "减持",
                    "40万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]